Skip to main content
Clinical Trials/IRCT20100827004641N18
IRCT20100827004641N18CompletedPhase 2

Comparition the impact of intraarticular Steroid and intraarticular ozon on improving the symptoms of osteoarthritis of knee

Physical Medicibe and Rehabilitaion Research Center of Tabriz0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
45 years to no limit (—)
Sex
All

Inclusion Criteria

  • Moderate Knee Osteoarthritis (grade two or three based Radiographic classification (Kellegren and Lawrence)
  • Existence of symptoms in favor of Knee Osteoarthritis for at least 3 months
  • Minimum score of 3 in the criterion (VAS)
  • Absence of Inflammatory Rheumatic diseases
  • 45 years old and older
  • Satisfaction of patients participating in the study
  • Failure to respond to Conservative drug treatments and physiotherapy lasted for 6 months

Exclusion Criteria

  • Severe Osteoarthritis (grade 4 candidates for joint replacement surgery)
  • Rheumatic disease Clearly
  • Visible deformity of the knee Ankylosis
  • Contraindications to Ozone include: Hyperthyroidism , Thrombocytopenia ,Pregnancy , Recent heart attack history ,G6PD Deficiency
  • Definitive and partial Contraindications to Steroid injection include: Bacteremia, Sepsis, Intra articular or pre uricular infection, History of post injection Allergy, Intra articular or Osteochondral fracture at the injection site, Severe Joint destruction in Injection site , Artificial joint , Uncontrolled Coagulation disorders Specific skin lesion at the injection site

Investigators

Sponsor
Physical Medicibe and Rehabilitaion Research Center of Tabriz

Similar Trials